Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,402 | -41,261 | -9,778 | -8,716 | 922 |
| Depreciation Amortization | 209 | 454 | 334 | 222 | 110 |
| Accounts receivable | -435 | -67 | -359 | 29 | 166 |
| Other Working Capital | -389 | -63 | -405 | 86 | 570 |
| Other Operating Activity | 803 | 36,720 | 7,465 | 7,094 | -2,123 |
| Operating Cash Flow | $-4,213 | $-4,217 | $-2,742 | $-1,285 | $-355 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -679 | -502 | -411 | -127 | -36 |
| Sale Of Investment | 5,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -7 | -58 | -23 | -22 | -19 |
| Other Investing Activity | -81 | -55 | -82 | -50 | -99 |
| Investing Cash Flow | $4,240 | $-558 | $-493 | $-176 | $-135 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 88 | 529 | 320 | N/A | 0 |
| Common Stock Issued | 1,136 | 10,868 | 3,675 | 1,906 | 400 |
| Other Financing Activity | -21 | -50 | -48 | -48 | -48 |
| Financing Cash Flow | $1,204 | $11,347 | $3,947 | $1,858 | $352 |
| Beginning Cash Position | 6,942 | 369 | 369 | 369 | 369 |
| End Cash Position | 8,173 | 6,942 | 1,081 | 766 | 231 |
| Net Cash Flow | $1,231 | $6,573 | $712 | $397 | $-138 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,213 | -4,217 | -2,742 | -1,285 | -355 |
| Capital Expenditure | -679 | -502 | -411 | -127 | -36 |
| Free Cash Flow | -4,892 | -4,719 | -3,153 | -1,411 | -391 |